Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes

Clinical and Experimental Allergy

Volumn 27, Issue 5, 1997, Pages 574-577

  Dekker, J W ^a   Nizankowska, E ^b   Schmitz Schumann, M ^c   Pile, K ^a   Bochenek, G ^b   Dyczek, A ^b   Cookson, W O C M ^a   Szczeklik, A ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c Hochgebirgsklinik   (Switzerland)

Author keywords

aspirin induced asthma; biochemical pathway

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ANTIGEN RECOGNITION; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTHMA; BRONCHOSPASM; DRUG INDUCED DISEASE; DRUG SENSITIVITY; ENZYME INHIBITION; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; PROVOCATION TEST;

ADULT; AGED; ALLELES; ALLERGENS; ASPIRIN; ASTHMA; BRONCHIAL PROVOCATION TESTS; FEMALE; HLA-DP ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; SKIN TESTS;

EID: 0030951312     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb00747.x     Document Type: Article

References (26)

1. Szczeklik A. Aspirin-Induced Asthma. In: Vane JR, Botting RM, eds. Aspirin and other salicylates. London, Chapman and Hall 1992: 548-75.
2. Christie PE, Tagari P, Ford-Hutchinson AW, et al. Urinary Leukotriene-E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991; 143: 1025-9.
3. Picado C, Ramis I, Rosello J et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992; 145: 65-9.
4. Sladek K, Dworski R, Soja J et al. Eicosanoids in bronchoalveolar fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 149: 940-6.
5. Israel E, Fischer AR, Rosenberg MA et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993; 148: 1447-51.
6. Kumlin M, Dahlen B, Bjorck T et al. Urinary excretion of Leukotriene E4 and 11-dehydro-Thromboxane B2 in response to Bronchial provocations with allergen, Aspirin, Leukotriene D4 and histamine in asthmatics. Am Rev Respir Dis 1992; 146: 96-103.
7. Drazen JM, O'Brien J, Sparrow D et al. Recovery of Leukotriene E4 from the urine of patients with airway obstruction. Am Rev Respir Dis 1992; 146: 104-6.
8. Ameisen JC, Capron A. Aspirin-sensitive asthma. Clin Exp Allergy 1990; 20: 127-30.
9. Mullarkey MF, Thomas PS, Hansen JA et al. Association of aspirin-sensitive asthma with HLA-DQw2. Am Rev Respir Dis 1986; 133: 261-63.
10. Schmitz-Schumann M, Menz, G, Virchow C et al. The HLA system and analgesic-induced asthma syndrome. Pneumologie 1990; 44 Suppl 1; 580-1.
11. Krishnamoorthy R. HLA class II haplotypes in aspirin-induced asthma. The genetics of asthma. Eds DG Marsh, A Lockhart, ST Holgate. Blackwell Scientific Publications, Oxford. 1993: 225-34.
12. Lympany PA, Welsh KI, Christie PE et al. An analysis with sequence-specific oligonucleotide probes of the association between aspirin-induced asthma and antigens of the HLA system. J Allergy Clin Immunol 1993; 92: 114-23.
13. Szczeklik A, Nizankowska E. Pharmacological agents in bronchial provocation tests. In Allegra L, Braga P, Dal Negro R, eds. Methods in asthmology. Raven Press, New York, 1990.
14. Szczeklik A, Nizankowska E. Asthme bronchique et medicaments anti-inflammatoires non-steroidiens. In Charpin J, Vervolet D, eds. Allergologie. Flammarion, Paris 1992.
15. Schmitz-Schumann M, Juhl E, Costabel E et al. Analgetika provokationsproben bei Analgetika-Asthma-Syndrom. Atemwegs Lungenkrakhl 1985; 1: 479-86.
16. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1990. Tissue Antigens 1991; 37: 97-104.
17. Dekker JW and Easteal E: HLA-DP typing by amplified fragment length polymorphisms (AFLPs). Immunogenetics 1990; 32: 56-9.
18. Wordsworth BP, Allsop CEM, Young RP et al. HLA-DR typing using DNA amplification by polymerase chain reaction and sequential hybridisation to sequence specific oligonucleotide probes. Immunogenetics 1990; 32: 413-8.
19. Young RP, Dekker JW, Wordsworth BP et al. HLA-DR and HLA-DP genotypes and Immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994; 24: 431-9.
20. Richeldi L, Sorrentino R and Saltini C. HLA-DPB1 Glutamate 69: A genetic marker of Beryllium Disease. Science 1993; 262: 242-4.
21. Bignon JS, Aron Y, Ju LY et al. Class II alleles in isocyanate-induced asthma. Am J Resp Crit Care Med 1994; 149: 71-5.
22. Young RP, Barker RD, Pile KD et al. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med 1995; 151: 219-21.
23. Fernandez-Vina M, Fink CW, Stastny P. HLA associations in juvenile arthritis. Clin Exp Rhematol 1994; 12: 205-14.
24. Szczeklik A. Aspirin-induced Asthma as a viral disease. Clinical Allergy 1988; 18: 15-20.
25. Szczeklik A, Schmitz-Schumann M, Nizankowska E et al. Altered distribution of IgG subclasses in aspirin-induced asthma: high IgG4, low IgG1. Clin Exp Allergy 1992; 22: 283-7.
26. Szczeklik A, Nizankowska E, Serafin A et al. Autoimmune phenomena in bronchial asthma, with special reference to aspirin intolerance. Am J Respir Crit Care Med 1995; 152: 1753-6.